SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

A 63-year-old retiree with $400,000 parked successful the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) apt picked it for the 100-stock surface and the reliable income stream. The apical 10 positions present marque up 41% of the fund, which means astir $164,000 of that nest ovum sits successful 10 names. For a money managing $94 billion, SCHD's attraction illustration deserves a person look earlier anyone treats it arsenic a one-ticker solution.

The strategy and the income motor

SCHD tracks the Dow Jones U.S. Dividend 100 Index, screening for companies with astatine slightest 10 consecutive years of dividend increases and beardown equilibrium sheets. The instrumentality motor is simple: cod dividends from mature, cash-generative bluish chips and fto the scale reconstitute erstwhile a twelvemonth successful March. Investors get a existent output of 3.27% astatine a 0.06% disbursal ratio, among the cheapest successful the category.

The surface has a existent borderline for retirees, arsenic names similar Merck (NYSE:MRK) raised its quarterly payout from $0.77 successful 2024 to $0.85 successful aboriginal 2026, and Bristol Myers Squibb (NYSE:BMY) nudged its quarterly dividend from $0.62 to $0.63 implicit the aforesaid window. Steady raises astatine the holding level construe into a unchangeable income level astatine the fund.

Heavier than the S&P 500 astatine the apical

The apical 10 names transportation idiosyncratic weights betwixt astir 3%: Qualcomm leads, followed by Texas Instruments, UnitedHealth, Chevron, Coca-Cola, ConocoPhilips, Verizon, and Amgen. The combined speechmaking of the apical stocks is heavier than the S&P 500's 36% top-10 concentration, adjacent though the header scale is famously crowded astatine the apical with mega-cap tech.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Schwab U.S. Dividend Equity ETF didn't marque the cut. Grab the names FREE today.

On the different hand, assemblage tilts compound the issue. Energy sits adjacent 16% aft the March 2026 reconstitution trimmed it from 24%, with 2 lipid majors successful the apical five. Healthcare runs astir 18%, anchored by 3 cause makers. Single-stock hazard wrong SCHD runs higher than the 100-name headcount suggests.